Neuroblastoma detection using serum proteomic profiling: A novel mining technique for cancer?

Journal of Pediatric Surgery

Volumn 41, Issue 4, 2006, Pages 639-646

  Sandoval, John A ^a   Dobrolecki, Lacey E ^a   Huang, Jeffrey ^a   Grosfeld, Jay L ^a   Hickey, Robert J ^a   Malkas, Linda H ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

Bioinformatics; Early detection; High risk neuroblastoma; Neuroblastoma; Proteomics; Serum profiling; Surface enhanced laser desorption ionization time of flight mass spectrometry

Indexed keywords

BIOLOGICAL MARKER; LACTATE DEHYDROGENASE; NEURON SPECIFIC ENOLASE; PLASMA PROTEIN; TUMOR MARKER;

ADOLESCENT; ALGORITHM; ARTICLE; CANCER SCREENING; CANCER STAGING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; INFANT; MALE; NEUROBLASTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; SIGNAL NOISE RATIO; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; VALIDATION STUDY;

CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; NEUROBLASTOMA; PROSPECTIVE STUDIES; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 33645295478     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2005.12.037     Document Type: Article

References (44)

1. W.G. Woods, R.N. Gao, and J.J. Shuster Screening of infants and mortality due to neuroblastoma N Engl J Med 346 14 2002 1041 1046
2. F.H. Schilling, C. Spix, and F. Berthold Neuroblastoma screening at one year of age N Engl J Med 346 14 2002 1047 1053
3. K. Yamamoto, S. Ohta, and E. Ito Marginal decrease in mortality and marked increase in incidence as a result of neuroblastoma screening at 6 months of age: cohort study in seven prefectures in Japan J Clin Oncol 20 5 2002 1209 1214
4. G.M. Brodeur, R.C. Seeger, and M. Schwab Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage Science 224 4653 1984 1121 1124
5. A. Nakagawara, M. Arima-Nakagawara, and N.J. Scavarda Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma N Engl J Med 328 12 1993 847 854
6. A. Nakagawara, C.G. Azar, and N.J. Scavarda Expression and function of TRK-B and BDNF in human neuroblastomas Mol Cell Biol 14 1 1994 759 767
7. E. Hiyama, K. Hiyama, and T. Yokoyama Correlating telomerase activity levels with human neuroblastoma outcomes Nat Med 1 3 1995 249 255
8. M.C. Favrot, V. Combaret, and C. Lasset CD44-a new prognostic marker for neuroblastoma N Engl J Med 329 26 1993 1965
9. M. Ohira, S. Oba, and Y. Nakamura A review of DNA microarray analysis of human neuroblastomas Cancer Lett 2005
10. J. Takita, M. Ishii, and S. Tsutsumi Gene expression profiling and identification of novel prognostic marker genes in neuroblastoma Genes Chromosomes Cancer 40 2 2004 120 132
11. J.S. MacNeil Better biomarkers for the diagnostics labyrinth Genome Technol 2004 1782 1787
12. M.A. Escobar, D.J. Hoelz, and J.A. Sandoval Profiling of nuclear extract proteins from human neuroblastoma cell lines: the search for fingerprints J Pediatr Surg 40 2 2005 349 358
13. J.A.. Sandoval, D.J. Hoelz, and H.A. Woodruff Novel peptides secreted from human neuroblastoma: useful clinical tools? J Pediatr Surg 41 2006 245 251
14. J.A. Mobley, Y.W. Lam, and K.M. Lau Monitoring the serological proteome: the latest modality in prostate cancer detection J Urol 172 1 2004 331 337
15. A.L. Feldman, V. Espina, and E.F. Petricoin III Use of proteomic patterns to screen for gastrointestinal malignancies Surgery 135 3 2004 243 247
16. T.C. Poon, T.T. Yip, and A.T. Chan Comprehensive proteomic profiling identifies serum proteomic signatures for detection of hepatocellular carcinoma and its subtypes Clin Chem 49 5 2003 752 760
17. J. Li, Z. Zhang, and J. Rosenzweig Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer Clin Chem 48 8 2002 1296 1304
18. E.F. Petricoin, A.M. Ardekani, and B.A. Hitt Use of proteomic patterns in serum to identify ovarian cancer Lancet 359 9306 2002 572 577
19. T.W. Hutchens, and T.T. Yip New desorption strategies for the mass spectrometric analysis of macromolecules Rapid Commun Mass Spectrom 7 1993 576 580
20. S.R. Weinberger, F.A. Dalmasso, and E.T. Fung Current achievements using ProteinChip Array Technology Curr Opin Chem Biol 6 2001 86 91
21. A. Weisner Detection of tumor markers with ProteinChip technology Curr Pharm Biotechnol 5 2004 45 67
22. A. Vlahou, P.F. Schellhammer, and S. Mendrinos Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine Am J Pathol 158 2001 1491 1501
23. B.L. Adam, Y. Qu, and J.W. Davis Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men Cancer Res 62 2002 3609 3614
24. G. Wright Jr, L.H. Cazares, and S.M. Leung Proteinchip (R) surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures Prostate Cancer Prostatic Dis 2 1999 264 276
25. E.F. Petricoin, A.M. Ardekani, and B.A. Hitt Use of proteomic patterns in serum to identify ovarian cancer Lancet 359 2002 572 577
26. A. Vlahou, J.O. Schorge, and B.W. Gregory Diagnosis of ovarian cancer using decision tree classification of mass spectral data J Biomed Biotechnol 2003 2003 308 314
27. A. Vlahou, C. Laronga, and L. Wilson A novel approach toward development of a rapid blood test for breast cancer Clin Breast Cancer 4 2003 203 209
28. T.C. Poon, T.T. Yip, and A.T. Chan Comprehensive proteomic profiling identifies serum proteomic signatures for detection of hepatocellular carcinoma and its subtypes Clin Chem 49 2003 752 760
29. J.T. Wadsworth, K.D. Somers, and B.C. Stack Jr Identification of patients with head and neck cancer using serum protein profiles Arch Otolaryngol Head Neck Surg 130 2004 98 104
30. T.A. Zhukov, R.A. Johanson, and A.B. Cantor Discovery of distinct protein profiles specific for lung tumors and pre-malignant lung lesions by SELDI mass spectrometry Lung Cancer 40 2003 267 279
31. J. Koopmann, Z. Zhang, and N. White Serum diagnosis of pancreatic adenocarcinoma using surface-enhanced laser desorption and ionization mass spectrometry Clin Cancer Res 10 2004 860 868
32. K.A. Baggerly, J.S. Morris, and J. Wang A comprehensive approach to the analysis of matrix-assisted laser desorption/ionization-time of flight proteomics spectra from serum samples Proteomics 3 9 2003 1667 1672
33. K.R. Coombes, H.A. Fritsche Jr, and C. Clarke Quality control and peak finding for proteomics data collected from nipple aspirate fluid by surface-enhanced laser desorption and ionization Clin Chem 49 10 2003 1615 1623
34. V. Combaret, C. Bergeron, and S. Brejon Protein chip array profiling analysis of sera from neuroblastoma patients Cancer Lett 228 2005 91 96
35. W.G. Woods, M. Tuchman, and L.L. Robison A population-based study of the usefulness of screening for neuroblastoma Lancet 348 9043 1996 1682 1687
36. Y. Tsubono, and S. Hisamichi A halt to neuroblastoma screening in Japan N Engl J Med 350 19 2004 2010 2011
37. T. Philip Early detection of neuroblastoma in infants: research? Yes. Routine screening? No Med Pediatr Oncol 33 4 1999 355 356
38. S.E. Bates, and D.L. Longo Tumor markers: value and limitations in the management of cancer patients Cancer Treat Rev 12 3 1985 163 207
39. E.P. Diamandis Analysis of serum proteomic patterns for early cancer diagnosis: drawing attention to potential problems J Natl Cancer Inst 96 5 2004 353 356
40. K.A. Baggerly, J.S. Morris, and S.R. Edmonson Signal in noise: evaluating reported reproducibility of serum proteomic tests for ovarian cancer J Natl Cancer Inst 97 4 2005 307 309
41. L.A. Liotta, M. Lowenthal, and A. Mehta Importance of communication between producers and consumers of publicly available experimental data J Natl Cancer Inst 97 4 2005 310 314
42. O.J. Semmes, Z. Feng, and B.L. Adam Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility Clin Chem 51 1 2005 102 112
43. N. Tang, P. Tornatore, and S.R. Weinberger Current developments in SELDI affinity technology Mass Spectrom Rev 23 1 2004 34 44
44. G. Kwapiszewska, M. Meyer, and R. Bogumil Identification of proteins in laser-microdissected small cell numbers by SELDI-TOF and tandem MS BMC Biotechnol 4 1 2004 30